Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...

A Chinese company has developed a new diabetes drug that could become a strong competitor to Ozempic and Monjauro as a weight ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...

These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...